The Canadian and the US cannabis index have been blossoming for some time. But many analysts have noted that the US index continues to flourish into each quarter. Where does the growth come from? California has been operating a flourishing medical cannabis industry for two decades and it is only fair that they become the cannabis powerhouse of the states as they welcomed recreational sales at the start of this year. In Ron Struthers opinion as published by Streetwise Reports, the next big investment to make is in, RISE Life Science Corp. (RLSC:CSE).
RISE makes consumer products that are focused on another thriving market: health & wellness. More finitely, they will be building a product suite that will carry sexual health products that can be introduced at a global scale. RISE proprietary formulas will be made using CBD-only and introduced to California before spreading throughout other US states. Once Canada is on-line with their regulatory condition RISE is planning to expand North.
The reason RISE is so attractive is because their product line can exist outside of the often confining regulations put onto THC. Using only farm-compliant hemp in their cannabis wellness products, the company is able to expand while still abiding by US Federal law, not an easy feat. Their recent acquisition of Cultivate Kind, a marketing & branding agency, as well as Life Bloom Organics, LLC., a California company with a specialty of oral CBD sprays, RISE is carefully positioning themselves within the lucrative West Coast cannabis market. With these facts and their sales team already infiltrating the 200 California dispensaries, it surely won’t be long until RISE is a household name.